CTOs on the Move

Nestle Skin Health

www.nestleskinhealth.com

 
Nestlé Skin Healths mission is to enhance peoples quality of life and contribute to a healthier future through science-based solutions for skin health, leading to our vision - to change the way the world thinks about skin health. As one of the categorys leading companies, Nestlé Skin Health conducts ground-breaking product research to provide both the healthcare community and the consumer with an ongoing progression of innovative technologies and products to protect, serve and enhance skin health.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Providien

Providien is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Second Sight

Second Sight is a Sylmar, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vital Proteins

We believe that whole food based nutrition containing collagen is essential for one`s overall health, beauty, fitness and well-being. Our ancestors utilized sustainable whole animal nutrition, which provided an abundant amount of collagen. Over the past century modern food processing has removed this natural and healthy protein from our diets. Collagen is vital for our body and is the basic building block of skin, hair, nails, bones and joints. We promote optimal health, beauty, vibrant youth, and overall wellness with our products. We are dedicated to providing 100% natural, whole food proteins that support animal well-being and sustainable eco-friendly practices. Our happy cows openly graze on lush natural grass pastures providing the highest quality of protein.

Chandler Group

Chandler Group is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cellenkos Incorporated

Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.